RxDoctor Payments Data

Mandy Gordon

Nurse Practitioner · Jonesboro, ARNPI 1497195598

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 573 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 14.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,294, 2.6 times the $1,258 reported in 2021. Among nurse practitioner clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,198in general payments, 2019–2025

Across 573 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$2K
  • AstraZeneca$1K
  • Johnson & Johnson$1K
  • Novartis$791
  • Incyte Corporation$581
  • GSK$490
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$5004%
  • Food & beverage$11,17892%
  • Education$5204%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.37$1,733
AstraZeneca(2 entities)42$1,099
Johnson & Johnson(2 entities)51$1,094
Novartis51$791
Incyte Corporation19$581
GSK25$490
AbbVie23$483
Merck23$441
Amgen26$436
Eisai Inc.23$405
Pfizer27$399
Sanofi14$246
Takeda Pharmaceuticals U.S.A., Inc.11$222
Exelixis Inc.14$219
Seagen Inc.10$215
Lilly USA, LLC12$194
Puma Biotechnology, Inc.11$176
E.r. Squibb & Sons, L.L.C.6$163
Pharmacyclics LLC, An Abbvie Company7$157
Regeneron Healthcare Solutions, Inc.7$142
AVEO Pharmaceuticals, Inc.8$136
Genentech USA, Inc.9$132
EMD Serono, Inc.3$129
Ipsen Biopharmaceuticals, Inc9$126
Stemline Therapeutics Inc.1$124
Boehringer Ingelheim5$119
Bayer7$115
Sobi, Inc6$106
Deciphera Pharmaceuticals Inc.6$105
Bristol Myers Squibb7$103
Astellas Pharma US Inc6$101
ADC Therapeutics America, Inc.6$91
Mirati Therapeutics, Inc.1$86
Beigene USA, Inc.5$81
Tersera Therapeutics LLC3$73
Beone Medicines USA, Inc.4$72
Dova Pharmaceuticals5$68
Pharmacosmos Therapeutics Inc.2$66
Pharmaessentia USA Corporation3$53
Iovance Biotherapeutics, Inc.3$50
Array Biopharma Inc3$47
Janssen Scientific Affairs, LLC1$47
Apellis Pharmaceuticals, Inc.2$46
G1 Therapeutics, Inc.3$44
Kyowa Kirin, Inc.2$38
Alnylam Pharmaceuticals Inc.2$36
Myovant Sciences Inc.2$36
Rigel Pharmaceuticals, Inc.3$35
Caris MPI, Inc.2$34
Dendreon Pharmaceuticals LLC2$30
Acceleron Pharma, Inc.2$23
Tempus AI, Inc1$20
UCB, Inc.1$18
Gilead1$16
Karyopharm Therapeutics Inc.1$15
AMAG Pharmaceuticals, Inc.1$15
Syndax Pharmaceuticals, Inc.1$14
Global Blood Therapeutics, Inc.1$13
Sumitomo Pharma America, Inc.1$13
Boston Scientific1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,198 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$2,889
Medicare patients
23
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone24$464
Potassium Chloride30$323

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Jonesboro

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →